Möchten Sie immer auf dem neuesten Stand bleiben?

Recce awarded grant of A$37,508 plus GST by the Australian Government Department of Industry, Science, Energy and Resources as part of the Entrepreneurs’ Programme. The grant will be directed towards...

SYDNEY Australia, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE), the Company developing new classes of synthetic anti-infectives, is pleased to announce the Board of...

SYDNEY, Australia, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE) (Company), the Company developing new classes of synthetic anti-infectives, today announced the appointment...

Highlights: New RECCE® 435 oral showed dose-dependent and efficacy against Helicobacter pylori (H. pylori) bacteria isolated from a patient with a duodenal ulcer compared to control vehicle in...

SYDNEY, Australia, July 27, 2020 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE) (Company), the Company developing New Classes of Synthetic Anti-infectives, today announced that it will be...

Highlights: International study will be conducted in a laboratory at a leading academic institution in the U.S. to evaluate anti-viral activity of RECCE® 327 and new antiviral formulation...

SYDNEY, Australia, July 14, 2020 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE) (Company), the Company developing new classes of synthetic anti-infectives, today announced the appointment...

Highlights: RECCE® 327 and New RECCE® 529 compounds were selected for their unique mechanisms of action against hyper-mutation, as indicated on bacteria and viruses (respectively)Testing program...

SYDNEY, Australia, July 06, 2020 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE) (Company), the Company developing new classes of broad-spectrum synthetic antibiotics, today announced the...

Highlights: Statistically significant reduction of Neisseria gonorrhoeae bacteria in reproductive organs of female miceRECCE® 327 outperformed market approved drug Meropenem in most instances ...